Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV)

CUSIP: 92539P101

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
89,600,000
Total 13F shares
72,945,086
Share change
-8,407,154
Total reported value
$819,295,389
Put/Call ratio
651%
Price per share
$11.23
Number of holders
171
Value change
+$44,434,673
Number of buys
90
Number of sells
125

Quarterly Holders Quick Answers

What is CUSIP 92539P101?
CUSIP 92539P101 identifies VERV - Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of VERV - Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV) as of Q2 2025

As of 30 Jun 2025, Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV) was held by 171 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 72,945,086 shares. The largest 10 holders included Alphabet Inc., BlackRock, Inc., Pentwater Capital Management LP, VANGUARD GROUP INC, Casdin Capital, LLC, FARALLON CAPITAL MANAGEMENT LLC, ALPINE ASSOCIATES MANAGEMENT INC., STATE STREET CORP, ARCH Venture Management, LLC, and UBS Group AG. This page lists 172 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
189
Q2 2025 holders
171
Holder diff
-18
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .